News Room
TP-102 Phase I/IIa clinical trial results published in Med by Cell Press
Technophage is excited to kick off the new year by sharing our latest publication in Med by Cell Press. Our Phase I/IIa study results for TP-102, an...
Technophage is looking for a Logistics/Supply chain Analyst to join the team
Technophage is currently looking for a Logistics/Supply chain Analyst to join our Quality and Manufacturing team. Technophage requires a degre in...
New INFARMED guidance on the use of phage therapy in the hospital context
Technophage congratulates INFARMED, I.P. on the approval of phage therapy in Portugal, a groundbreaking achievement celebrated alongside the release...
Pipeline
Invest in our products
GMP manufacturing
Learn more about GMP manufacturing
Technophage
Who we are, What we do
Therapeutic
areas
TechnoPhage is committed to the development of biological and chemical products for infection, neurosciences and ophthalmology